NIM
TEVA icon

NuWave Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

NuWave Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$515K Buy
+63,780
New +$564K 0.59% 57
2022
Q1 		– Sell
-22,648
Closed -$181K – 377
2021
Q4 		$181K Buy
+22,648
New +$204K 0.21% 155
2021
Q3 		– Sell
-16,740
Closed -$166K – 416
2021
Q2 		$166K Buy
+16,740
New +$177K 0.18% 170
2021
Q1 		– Sell
-15,308
Closed -$148K – 418
2020
Q4 		$148K Sell
15,308
-16,397
-52% -$157K 0.19% 143
2020
Q3 		$286K Buy
31,705
+31,157
+5,686% +$330K 0.44% 71
2020
Q2 		$7K Buy
+548
New +$6.2K 0.01% 351
2020
Q1 		– Sell
-22,823
Closed -$223K – 390
2019
Q4 		$223K Sell
22,823
-6,524
-22% -$58.2K 0.22% 159
2019
Q3 		$198K Sell
29,347
-2,371
-7% -$18.2K 0.2% 148
2019
Q2 		$293K Buy
31,718
+30,490
+2,483% +$368K 0.31% 105
2019
Q1 		$19K Sell
1,228
-22,848
-95% -$403K 0.02% 272
2018
Q4 		$371K Buy
+24,076
New +$494K 0.63% 57
2018
Q3 		– Sell
-159
Closed -$4K – 429
2018
Q2 		$4K Buy
+159
New +$3.24K 0.01% 249
2018
Q1 		– Sell
-102
Closed -$2K – 349
2017
Q4 		$2K Buy
+102
New +$1.53K ﹤0.01% 322
2014
Q3 		$59K Buy
1,087
+903
+491% +$47.8K 0.17% 141
2014
Q2 		$10K Sell
184
-6,066
-97% -$310K 0.03% 248
2014
Q1 		$331K Buy
6,250
+6,191
+10,493% +$286K 0.98% 25
2013
Q4 		$2K Sell
59
-164
-74% -$6.46K ﹤0.01% 287
2013
Q3 		$8K Sell
223
-13,962
-98% -$545K 0.01% 268
2013
Q2 		$556K Buy
+14,185
New +$552K 0.61% 64

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

NuWave Investment Management's TEVA Position: Q3 2022 in Review

NuWave Investment Management opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2022: 63,780 shares worth $515K. The stake represents 0.59% of the portfolio and ranks #57 among its holdings. This is a return to the name: NuWave Investment Management previously reported a position in TEVA as recently as Q4 2021.

NuWave Investment Management first reported a position in TEVA in Q2 2013 and has held it in 19 quarters since. The position peaked at $556K in Q2 2013. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • NuWave Investment Management held 63,780 shares of Teva Pharmaceuticals worth $515K as of Q3 2022.
  • Teva Pharmaceuticals was a new NuWave Investment Management position in Q3 2022.
  • Teva Pharmaceuticals made up 0.59% of NuWave Investment Management's portfolio in Q3 2022, its #57 holding.
  • NuWave Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 19 quarters since.
  • NuWave Investment Management's Teva Pharmaceuticals position peaked at $556K in Q2 2013.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on NuWave Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.